These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29303101)

  • 21. Clinical experiences with testosterone therapy: prostate safety.
    Ebert T
    Aging Male; 2004 Dec; 7(4):304-11. PubMed ID: 15799126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Late-onset hypogonadism.
    Bassil N
    Med Clin North Am; 2011 May; 95(3):507-23, x. PubMed ID: 21549875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigating the basis of sexual dysfunction during late-onset hypogonadism.
    Tharakan T; Miah S; Jayasena C; Minhas S
    F1000Res; 2019; 8():. PubMed ID: 30984376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transrectal ultrasound (TRUS) findings of the prostate gland in late onset hypogonadism with testosterone supplementation in correlation with clinical outcome.
    Phongkitkarun S; Rassameepong A; Permpongkosol S; Taphey M; Wibulpolprasert B
    J Med Assoc Thai; 2012 Jul; 95(7):953-9. PubMed ID: 22919992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Testosterone and bone: indications and limitations].
    Stoll D; Puder JJ; Lamy O
    Rev Med Suisse; 2011 Jun; 7(299):1311-5. PubMed ID: 21793421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.
    Wang C; Swerdloff RS; Iranmanesh A; Dobs A; Snyder PJ; Cunningham G; Matsumoto AM; Weber T; Berman N;
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2839-53. PubMed ID: 10946892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
    Blick G
    Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and management of male androgen disorders: an update.
    Chan I; Fui MN; Zajac JD; Grossmann M
    Aust Fam Physician; 2014 May; 43(5):277-82. PubMed ID: 24791767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 12-month observation of testosterone replacement effectiveness in a general population of men.
    Miner MM; Bhattacharya RK; Blick G; Kushner H; Khera M
    Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prospective assessment of health-related quality of life in men with late-onset hypogonadism who received testosterone replacement therapy.
    Sumii K; Miyake H; Enatsu N; Matsushita K; Fujisawa M
    Andrologia; 2016 Mar; 48(2):198-202. PubMed ID: 25988884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only.
    Yassin AA; Saad F
    J Sex Med; 2007 Mar; 4(2):497-501. PubMed ID: 17367445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late-onset Hypogonadism and Testosterone Therapy - A Summary of Guidelines from the American Urological Association and the European Association of Urology.
    Fode M; Salonia A; Minhas S; Burnett AL; Shindel AW
    Eur Urol Focus; 2019 Jul; 5(4):539-544. PubMed ID: 30858073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testosterone Therapy: Review of Clinical Applications.
    Petering RC; Brooks NA
    Am Fam Physician; 2017 Oct; 96(7):441-449. PubMed ID: 29094914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
    Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
    Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hypoactive sexual desire and testosterone deficiency in men].
    Lejeune H; Huyghe É; Droupy S
    Prog Urol; 2013 Jul; 23(9):621-8. PubMed ID: 23830256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of prostate cancer in hypogonadal men receiving testosterone therapy: observations from 5-year median followup of 3 registries.
    Haider A; Zitzmann M; Doros G; Isbarn H; Hammerer P; Yassin A
    J Urol; 2015 Jan; 193(1):80-6. PubMed ID: 24980615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores.
    Corona G; Rastrelli G; Morgentaler A; Sforza A; Mannucci E; Maggi M
    Eur Urol; 2017 Dec; 72(6):1000-1011. PubMed ID: 28434676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.